News Channels

12 Jul 2018 Ovid Therapeutics Announces Initiation of Phase 2 ROCKET Clinical Trial to Evaluate OV101 in Fragile X Syndrome
12 Jul 2018 Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen) in the European Union
12 Jul 2018 UroGen Pharma Submits Investigational New Drug (IND) Application for UGN-102 (VesiGel™) for the Treatment of Low-Grade Non-Muscle Invasive Bladder Cancer (LG NMIBC)
12 Jul 2018 Osiris Announces Enrollment of Patients in a Clinical Trial Evaluating GrafixPL PRIME™ in the Treatment of Chronic Venous Leg Ulcers
12 Jul 2018 Saniona receives milestone payment from Boehringer Ingelheim
12 Jul 2018 Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies
11 Jul 2018 MorphoSys Announces its Licensee Janssen has Initiated a Phase 2/3 Program (GALAXI) to Evaluate Tremfya(R) (Guselkumab) in Crohn's Disease
11 Jul 2018 VIVUS Announces Positive Results from a Phase 1 Clinical Trial of VI-0106
11 Jul 2018 FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Advanced Hepatocellular Carcinoma
11 Jul 2018 Bristol-Myers Squibb’s Opdivo® (nivolumab) + Low-Dose Yervoy® (ipilimumab) is the First Immuno-Oncology Combination Approved for MSI-H/dMMR mCRC Patients Who Progressed Following Treatment with a Fluoropyrimidine, Oxaliplatin and Irinotecan
11 Jul 2018 Otsuka Pharmaceutical to Acquire Visterra
11 Jul 2018 Cara Therapeutics Announces Dosing of Patients in Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin) for Pruritus in Stage III-V Chronic Kidney Disease (CKD) Patients
11 Jul 2018 Idera Pharmaceuticals Announces Termination of Merger Agreement with BioCryst Pharmaceuticals
11 Jul 2018 Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Nivolumab in Metastatic Colorectal Cancer
10 Jul 2018 Tetra Discovery Partners Initiates Phase 2 Trial of BPN14770 in Fragile X Syndrome
10 Jul 2018 BioNTech and Genevant Sciences Sign Strategic mRNA-Focused Partnership in Rare Diseases
10 Jul 2018 VALBIOTIS Announces Positive Results from First Phase I/II Clinical Study of VAL-070 in Hypercholesterolemia
10 Jul 2018 PTC Therapeutics Announces Positive Data from its Translarna™ Phase II Clinical Trial in Children as Young as Two Years with Nonsense Mutation Duchenne Muscular Dystrophy
10 Jul 2018 Adlai Nortye Announce Global License Agreement for Buparlisib (BKM120)
10 Jul 2018 Aeromics Initiates Phase 1 Clinical Trial of CNS Edema Inhibitor AER-271 In Healthy Human Volunteers

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top